A quick classification note: glutathione is technically a tripeptide — three amino acids (glutamate, cysteine, glycine) — so unlike NAD+ it does fit the chemical definition of a peptide. But it works as your body's master antioxidant, not as a signaling "peptide drug" like BPC-157, which is why we treat it separately. Our injectable glutathione card gives the short version; this guide covers what the evidence actually supports, and the serious safety flags that come with the most popular use.
- Glutathione is the body's dominant intracellular antioxidant and a key player in liver detoxification.
- IV/injectable glutathione is marketed for detox, immunity, and — by far the biggest real-world use — skin lightening.
- The best-designed Parkinson's trial was essentially negative, and skin-whitening efficacy evidence is weak.
- Regulators have flagged serious harms from high-dose IV glutathione for whitening — this is the section to read carefully.
What it is, and why the claims sound plausible
Glutathione is the most abundant antioxidant inside your cells, and it's central to how the liver neutralizes toxins and byproducts of metabolism. That real, important role is the seed of the marketing: if glutathione protects and detoxifies, the logic goes, more of it — delivered straight into a vein — must be better. The problem is that this leap isn't supported by good human outcome data, and the route carries risks the pitch leaves out. Notably, you don't need a needle to raise glutathione: the NAC and glycine on our supplement list rebuild it from the inside, and even oral glutathione itself can raise body stores.
What the research actually shows
Parkinson's disease
Glutathione's most serious medical testing has been in Parkinson's. An early open-label study reported symptom improvement, but open-label designs can't rule out placebo. The better-designed follow-up — a randomized, double-blind pilot giving IV glutathione (1,400 mg) three times weekly — found only a small, statistically non-significant symptomatic signal that faded after treatment stopped.[1] In other words, the controlled evidence is modest at best.
Raising glutathione (and why the needle may be unnecessary)
A 6-month randomized controlled trial showed that oral glutathione supplementation raised the body's glutathione stores.[2] That undercuts a core assumption behind the drips — that injection is the only way to move the needle on glutathione levels.
Skin whitening
This is the dominant real-world use, especially across parts of Asia, where IV glutathione is promoted to lighten skin by suppressing melanin. But the human efficacy evidence for the injectable route is weak, with no established dosing or safety protocol — and, as below, this use is exactly where the serious harms cluster.
The honest bottom line: glutathione is vital biochemistry, but injecting it is a weakly supported intervention for anything — and an actively dangerous one when used to lighten skin.
Selected Research
- Hauser et al., Movement Disorders, 2009 — randomized, double-blind pilot: IV glutathione (1,400 mg) in Parkinson's produced only a small, non-significant symptom change that did not persist. PubMed
- Richie et al., European Journal of Nutrition, 2015 — 6-month randomized controlled trial: oral glutathione supplementation raised body glutathione stores. PubMed
- Philippine Food and Drug Administration, Advisory No. 2019-182 — warns that IV glutathione for skin lightening is unsafe and linked to serious adverse effects. FDA (PH)
IV glutathione is not FDA-approved for skin lightening, detox, or anti-aging, and its efficacy evidence is weak. Cited for education only — not medical advice or a recommendation. Individual responses and risks vary.